An estimated 53 drugs would not enter the market in the next 30 years if the NIH is hit with a permanent 10% budget cut and the FDA experiences a nine-month drug review delay due to staffing cuts, the ...

Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a ...

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

In FDA job cuts, experts see threat of far-reaching impact The Trump administration’s move to reduce the FDA’s workforce could imperil important work on devices and food safety, as well as ...

HAMPTON, VA. — Food plant inspections by the US Food and Drug Administration might be reduced as the result of deep staffing cuts under the Trump administration and Robert F. Kennedy Jr ...

Whitaker said he heard between 230 and 240 people were cut at the Center for Devices and Radiological Health, and Brooke said he heard from FDA sources that more than 200 people were cut. The CDRH ...

Whither reviews: An HHS fact sheet said the cuts aren’t supposed to impact FDA drug, ... (D-Colo.) in response to questioning about agency staffing levels. ...

FDA staffing cuts began in February 2025 and, on April 1, 2025, a predicted 3,500 full-time FDA employees—about 19% of the agency’s workforce—were subject to a US Department of Health and ...

Curay, the acting director of the FDA’s Center for Drug Evaluation and Research, internally announced her retirement Monday.

According to a former FDA official who spoke with The Hill, the staffing cuts at the agency will dethrone the U.S. as the “gold standard” on drug approvals.